Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Lauer

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Nature|May 18, 2017
Chromatin states define tumour-specific T cell dysfunction and reprogrammingMary Philip, Lauren Fairchild, Liping Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Recombinant <i>Listeria</i> promotes tumor rejection by CD8<sup>+</sup> T cell-dependent remodeling of the tumor microenvironmentWeiwen Deng, Victor Lira, Thomas E Hudson, et al.
Infection and Immunity|June 26, 2019
A Potent and Effective Suicidal <i>Listeria</i> Vaccine PlatformWilliam G Hanson, Erin L Benanti, Edward E Lemmens, et al.
Journal for Immunotherapy of Cancer|May 23, 2019
Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodiesVictoria M Kim, Alex B Blair, Peter Lauer, et al.
Immunity|August 14, 2016
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during TumorigenesisAndrea Schietinger, Mary Philip, Varintra E Krisnawan, et al.
Gastroenterology|March 11, 2014
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of miceBridget P Keenan, Yvonne Saenger, Michel I Kafrouni, et al.
Nature|November 30, 2021
An autoimmune stem-like CD8 T cell population drives type 1 diabetesSofia V Gearty, Friederike Dündar, Paul Zumbo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2008
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malariaNathan W Schmidt, Rebecca L Podyminogin, Noah S Butler, et al.
Science Translational Medicine|April 17, 2015
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockadeJuan Fu, David B Kanne, Meredith Leong, et al.
Prostate Cancer and Prostatic Diseases|July 14, 2021
Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancerCharles G Drake, Russell K Pachynski, Sumit K Subudhi, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Nature|May 18, 2017
Chromatin states define tumour-specific T cell dysfunction and reprogrammingMary Philip, Lauren Fairchild, Liping Sun, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2018
Recombinant <i>Listeria</i> promotes tumor rejection by CD8<sup>+</sup> T cell-dependent remodeling of the tumor microenvironmentWeiwen Deng, Victor Lira, Thomas E Hudson, et al.
Infection and Immunity|June 26, 2019
A Potent and Effective Suicidal <i>Listeria</i> Vaccine PlatformWilliam G Hanson, Erin L Benanti, Edward E Lemmens, et al.
Journal for Immunotherapy of Cancer|May 23, 2019
Anti-pancreatic tumor efficacy of a Listeria-based, Annexin A2-targeting immunotherapy in combination with anti-PD-1 antibodiesVictoria M Kim, Alex B Blair, Peter Lauer, et al.
Immunity|August 14, 2016
Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during TumorigenesisAndrea Schietinger, Mary Philip, Varintra E Krisnawan, et al.
Gastroenterology|March 11, 2014
A Listeria vaccine and depletion of T-regulatory cells activate immunity against early stage pancreatic intraepithelial neoplasms and prolong survival of miceBridget P Keenan, Yvonne Saenger, Michel I Kafrouni, et al.
Nature|November 30, 2021
An autoimmune stem-like CD8 T cell population drives type 1 diabetesSofia V Gearty, Friederike Dündar, Paul Zumbo, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2008
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malariaNathan W Schmidt, Rebecca L Podyminogin, Noah S Butler, et al.
Science Translational Medicine|April 17, 2015
STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockadeJuan Fu, David B Kanne, Meredith Leong, et al.
Prostate Cancer and Prostatic Diseases|July 14, 2021
Safety and preliminary immunogenicity of JNJ-64041809, a live-attenuated, double-deleted Listeria monocytogenes-based immunotherapy, in metastatic castration-resistant prostate cancerCharles G Drake, Russell K Pachynski, Sumit K Subudhi, et al.
Pageof 5